Neuron-specific enolase in testicular cancer - Clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up

Acta Oncologica

Volumn 42, Issue 3, 2003, Pages 202-206

  Tandstad, Torgrim ^a   Klepp, Olbjørn ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DIAGNOSIS; NEUROLOGY; TUMORS;

NEURON-SPECIFIC ENOLASE (NSE);

PATIENT MONITORING;

CHORIONIC GONADOTROPIN BETA SUBUNIT; NEURON SPECIFIC ENOLASE;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME BLOOD LEVEL; HUMAN; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SEMINOMA; TESTIS CANCER;

FALSE POSITIVE REACTIONS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; ORCHIECTOMY; PHOSPHOPYRUVATE HYDRATASE; PROGNOSIS; RETROSPECTIVE STUDIES; SEMINOMA; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0038200662     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310010727     Document Type: Article

References (13)

1. Warde P, Jewett MA. Surveillance for stage I testicular seminoma. Is it a good option? Urol Clin North Am 1998; 25: 425-33.
2. Klepp O, Dahl O, Flodgren P, et al. Risk-adapted treatment of clinical stage I non-seminomatous testis cancer. Eur J Cancer 1997; 33: 1038-44.
3. Sternberg CN. The management of stage I testis cancer. Urol Clin North Am 1998; 25: 435-49.
4. Horwich A. Questions in the management of seminoma. Clin Oncol 1990; 2: 249-53.
5. Raghavan D. Active surveillance" for stage 1 testis cancer: attaining maturity at 21 years. Eur J Cancer 2000; 36: 1891-4.
6. Fosså A, Fosså SD. Serum lactatedehydrogenase and human choriogonadotrophin in seminoma. Br J Urol 1984; 63: 408-15.
7. Cooper EH. Neuron-specific enolase. Int J Biol Mark 1994; 9: 205-10.
8. Niehans GA, Manivel C, Copland GT, Scheithauer BW, Wick MR. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 1988; 62: 1113-23.
9. Fosså SD, Klepp O, Paus E. Neuron-specific enolase - a serum tumour marker in seminoma? Br J Cancer 1992; 65: 297-9.
10. Kuzmits R, Schernthaner G, Krisch K. Serum neuron-specific enolase - a marker for response to therapy in seminoma. Cancer 1987; 60: 1017-21.
11. Gross AJ, Dieckmann KP. Neuron-specific enolase: a serum tumor marker in malignant germ-cell tumors? Eur Urol 1993; 24: 277-8.
12. Horwich A, Brada M, Nicholls J, et al. Intensive induction chemotherapy for poor risk nonseminomatous germ cell tumours. Eur J Cancer 1989; 25: 177-84.
13. Giovanella L, Ceriani L, Bandera M, Garancini S. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase. Int J Biol Mark 2001; 16: 50-5.